Evidence map›Paper›PMID 30185869›Full record

ArticleScientific reports2018

Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity.

Saray Varona, Mar Orriols, María Galán, Anna Guadall, Laia Cañes, Silvia Aguiló, Marc Sirvent, José Martínez-González, Cristina Rodríguez

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Recombinant lysyl oxidase effects on embryonic tendon cell phenotype and behavior.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  7. Article
  8. Article
  9. Total Panax notoginseng saponin inhibits balloon injury-induced neointimal hyperplasia in rat carotid artery models by suppressing pERK/p38 MAPK pathways.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  10. Review
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Saray VaronaInstituto de Investigaciones Biomédicas de Barcelona (IIBB-CSIC), Barcelona, Spain.
Mar OrriolsCIBER de Enfermedades Cardiovasculares (CIBERCV), ISCIII, Madrid, Spain.
María GalánCIBER de Enfermedades Cardiovasculares (CIBERCV), ISCIII, Madrid, Spain.
Anna GuadallInstituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Laia CañesInstituto de Investigaciones Biomédicas de Barcelona (IIBB-CSIC), Barcelona, Spain.
Silvia AguilóInstituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Marc SirventHospital Universitari Germans Trias i Pujol, Badalona, Spain.
José Martínez-GonzálezInstituto de Investigaciones Biomédicas de Barcelona (IIBB-CSIC), Barcelona, Spain. jose.martinez@iibb.csic.es.
Cristina RodríguezCIBER de Enfermedades Cardiovasculares (CIBERCV), ISCIII, Madrid, Spain. crodriguezs@santpau.cat.
Hospital de Sant Pau · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital Universitari Germans Trias i Pujol · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysyl oxidase (LOX) plays a critical role in extracellular matrix maturation and limits VSMC proliferation and vascular remodeling. We have investigated whether this anti-proliferative effect relies on the extracellular catalytically active LOX or on its biologically active propeptide (LOX-PP). High expression levels of both LOX and LOX-PP were detected in the vascular wall from transgenic mice over-expressing the full-length human LOX cDNA under the control of SM22α promoter (TgLOX), which targets the transgene to VSMC without affecting the expression of mouse LOX isoenzymes. TgLOX VSMC also secrete high amounts of both mature LOX and LOX-PP. Wild-type (WT) mouse VSMC exposed to VSMC supernatants from transgenic animals showed reduced proliferative rates (low [

Indexed as

AminopropionitrileAnimalsCell ProliferationCells, CulturedCulture Media, ConditionedHumansMiceMice, TransgenicMuscle, Smooth, VascularMyocytes, Smooth MuscleNeointimaPromoter Regions, GeneticProtein-Lysine 6-OxidaseUp-RegulationAminopropionitrileCulture Media, ConditionedLOX protein, humanProtein-Lysine 6-Oxidase

Identifiers

PMID30185869
PMCPMC6125287
OpenAlexW2889055970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.